| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 TPTE2 SLC12A8 SLC39A10 SLCO1B1 AQP4 ABCA10 SLC2A1 CHRNB1 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P SLC44A5 ABCA5 KCNF1 SLC15A4 GLRB SLC49A4 ABCD4 CACNA1G | 3.79e-13 | 1180 | 107 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 TPTE2 SLC12A8 SLC39A10 SLCO1B1 AQP4 ABCA10 SLC2A1 CHRNB1 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 GPIHBP1 CLCA3P SLC44A5 ABCA5 KCNF1 SLC15A4 GLRB SLC49A4 ABCD4 CACNA1G | 5.99e-13 | 1289 | 107 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 5.96e-11 | 14 | 107 | 6 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 TPTE2 SLC12A8 SLC39A10 CHRNB1 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 GLRB CACNA1G | 1.79e-10 | 793 | 107 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 CACNA1G | 4.41e-10 | 465 | 107 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 AQP4 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 GLRB CACNA1G | 5.08e-10 | 758 | 107 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CLCA3P CACNA1G | 1.84e-09 | 129 | 107 | 10 | GO:0005262 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 CHRNB1 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 CACNA1G | 2.24e-09 | 664 | 107 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 AQP4 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB CACNA1G | 2.77e-09 | 525 | 107 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 AQP4 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB CACNA1G | 2.85e-09 | 526 | 107 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB CACNA1G | 2.99e-09 | 459 | 107 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 KCNF1 GLRB CACNA1G | 3.06e-09 | 334 | 107 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 CACNA1G | 4.31e-09 | 343 | 107 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPCN1 KCNA2 KCNA3 KCNF1 CACNA1G | 4.33e-09 | 184 | 107 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.69e-09 | 46 | 107 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 CACNA1G | 5.94e-09 | 627 | 107 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CLCA3P CACNA1G | 8.50e-09 | 151 | 107 | 10 | GO:0015085 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 KCNA2 KCNA3 KCNF1 CACNA1G | 9.06e-09 | 152 | 107 | 10 | GO:0022843 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 KCNA2 KCNA3 KCNF1 CACNA1G | 5.06e-08 | 182 | 107 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.48e-06 | 5 | 107 | 3 | GO:0086007 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.23e-05 | 9 | 107 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.23e-05 | 9 | 107 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 2.84e-05 | 2 | 107 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity | 8.50e-05 | 3 | 107 | 2 | GO:0097682 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 8.50e-05 | 3 | 107 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 8.50e-05 | 3 | 107 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.15e-04 | 18 | 107 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC11A2 SLC12A8 SLC39A10 SLCO1B1 ABCA10 SLC4A2 SLC44A5 ABCA5 SLC15A4 ABCD4 | 2.45e-04 | 477 | 107 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 2.81e-04 | 5 | 107 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 2.81e-04 | 5 | 107 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.56e-04 | 26 | 107 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 4.20e-04 | 180 | 107 | 6 | GO:0004866 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.21e-04 | 6 | 107 | 2 | GO:1905030 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 5.14e-04 | 187 | 107 | 6 | GO:0030414 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.03e-04 | 31 | 107 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 6.03e-04 | 31 | 107 | 3 | GO:0080025 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.26e-04 | 33 | 107 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 7.51e-04 | 201 | 107 | 6 | GO:0061135 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.08e-03 | 296 | 107 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.69e-03 | 44 | 107 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.30e-03 | 49 | 107 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 2.62e-03 | 257 | 107 | 6 | GO:0061134 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.73e-03 | 52 | 107 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 3.25e-03 | 16 | 107 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.84e-03 | 193 | 107 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.86e-03 | 119 | 107 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.10e-03 | 196 | 107 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | long-chain fatty acid transmembrane transporter activity | 4.12e-03 | 18 | 107 | 2 | GO:0005324 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 4.12e-03 | 18 | 107 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.12e-03 | 18 | 107 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.19e-03 | 197 | 107 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.60e-03 | 125 | 107 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.98e-03 | 293 | 107 | 6 | GO:0008514 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SPINK1 TPTE2 CDH23 CP SLC12A8 SLC39A10 SLCO1B1 CHRNB1 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 GLRB CACNA1G LTF | 1.47e-09 | 1374 | 108 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SPINK1 CDH23 CP SLC12A8 SLC39A10 CHRNB1 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 CACNA1G LTF | 2.51e-08 | 1157 | 108 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC11A2 SLC12A8 SLC39A10 SLC2A1 SLC15A4 CACNA1G | 3.49e-08 | 230 | 108 | 11 | GO:0098739 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SPINK1 CDH23 CP SLC12A8 SLC39A10 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 CACNA1G LTF | 4.48e-08 | 1000 | 108 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC11A2 SLC12A8 SLC39A10 CACNA1G | 5.91e-08 | 142 | 108 | 9 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC11A2 SLC12A8 SLC39A10 CACNA1G | 5.91e-08 | 142 | 108 | 9 | GO:0098659 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 TPTE2 SLC12A8 SLC39A10 CHRNB1 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 GLRB CACNA1G | 6.10e-08 | 1115 | 108 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.84e-07 | 48 | 108 | 6 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.84e-07 | 48 | 108 | 6 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 SLC39A13 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 GLRB CACNA1G | 2.83e-07 | 1017 | 108 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | calcium ion import | 8.29e-07 | 98 | 108 | 7 | GO:0070509 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 CACNA1G | 1.34e-06 | 922 | 108 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 SLC12A8 SLC39A10 SLC39A13 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 SLC15A4 CACNA1G | 1.82e-06 | 942 | 108 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | action potential | 1.08e-05 | 201 | 108 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SPINK1 CDH23 RYR2 TPCN1 CLCA3P CACNA1G | 1.46e-05 | 509 | 108 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 1.63e-05 | 10 | 108 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 1.63e-05 | 10 | 108 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.88e-05 | 217 | 108 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 2.23e-05 | 11 | 108 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 CDH23 CP SLC12A8 SLC39A10 AQP4 ADCY6 SLC39A13 RYR2 SLC4A2 GIP GPIHBP1 ABCA5 FSHR | 2.41e-05 | 1249 | 108 | 19 | GO:0048878 |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 2.72e-05 | 2 | 108 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 2.72e-05 | 2 | 108 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 2.72e-05 | 2 | 108 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 2.87e-05 | 113 | 108 | 6 | GO:0000041 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 2.92e-05 | 34 | 108 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 2.97e-05 | 12 | 108 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 2.97e-05 | 12 | 108 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CLCA3P CACNA1G | 4.06e-05 | 392 | 108 | 10 | GO:0070588 |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1D CACNA1E CACNA1F OR5T1 CDH23 TAAR5 RS1 AQP4 GFY OPRPN GIP TAS2R13 KCNA2 OR56B1 GLRB OR56A5 CA6 | 4.07e-05 | 1072 | 108 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 6.07e-05 | 15 | 108 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 8.12e-05 | 3 | 108 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 8.12e-05 | 3 | 108 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.25e-04 | 284 | 108 | 8 | GO:0007626 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1C CACNA1D NTRK2 CHRNB1 RYR2 KCNA2 KCNA3 KCNF1 GLRB CACNA1G LTF | 1.69e-04 | 559 | 108 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 CDH23 CP SLC39A10 AQP4 SLC39A13 RYR2 SLC4A2 FSHR | 1.70e-04 | 866 | 108 | 14 | GO:0055082 |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 CDH23 CP SLC12A8 SLC39A10 AQP4 SLC39A13 RYR2 SLC4A2 FSHR | 1.80e-04 | 981 | 108 | 15 | GO:0019725 |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 2.29e-04 | 23 | 108 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.59e-04 | 59 | 108 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 2.69e-04 | 5 | 108 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2.69e-04 | 5 | 108 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.14e-04 | 62 | 108 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 3.63e-04 | 116 | 108 | 5 | GO:0008344 | |
| GeneOntologyBiologicalProcess | amide transport | CACNA1C CACNA1D CACNA1E SPINK1 F2RL2 SLCO1B1 SGPP1 GIP SLC15A4 | 3.65e-04 | 420 | 108 | 9 | GO:0042886 |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 4.02e-04 | 6 | 108 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 4.02e-04 | 6 | 108 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1B CACNA1C CACNA1D CACNA1E TPCN2 SPINK1 NTRK2 WLS F2RL2 GIP KCNA2 CACNA1G | 4.97e-04 | 740 | 108 | 12 | GO:1903530 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 5.05e-04 | 266 | 108 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 5.90e-04 | 129 | 108 | 5 | GO:0002027 | |
| GeneOntologyBiologicalProcess | adult behavior | 7.02e-04 | 203 | 108 | 6 | GO:0030534 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type peptidase activity | 7.45e-04 | 8 | 108 | 2 | GO:1902572 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type endopeptidase activity | 7.45e-04 | 8 | 108 | 2 | GO:1900004 | |
| GeneOntologyBiologicalProcess | behavior | CHL1 CACNA1B CACNA1C CACNA1E SLC11A2 NTRK2 CDH23 TAAR5 CHRNB1 GIP KCNA2 GLRB FSHR | 7.75e-04 | 891 | 108 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 8.79e-04 | 36 | 108 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CACNA1D OR5T1 GPR34 TAAR5 F2RL2 ADCY6 OPRPN GIP TAS2R13 OR56B1 TMEM145 GLRB FSHR OR56A5 CCR6 C5 CXCL8 | 9.13e-04 | 1395 | 108 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | intracellular water homeostasis | 9.55e-04 | 9 | 108 | 2 | GO:0009992 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1B CACNA1C CACNA1D CACNA1E TPCN2 SPINK1 NTRK2 WLS F2RL2 GIP KCNA2 CACNA1G | 9.93e-04 | 801 | 108 | 12 | GO:0051046 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.13e-03 | 87 | 108 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.17e-03 | 224 | 108 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1C CACNA1F TPCN2 SLC11A2 CDH23 CP SLC12A8 SLC39A10 SLC39A13 RYR2 SLC4A2 | 1.17e-03 | 705 | 108 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | regulation of serine-type peptidase activity | 1.19e-03 | 10 | 108 | 2 | GO:1902571 | |
| GeneOntologyBiologicalProcess | regulation of serine-type endopeptidase activity | 1.19e-03 | 10 | 108 | 2 | GO:1900003 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.20e-03 | 40 | 108 | 3 | GO:0045762 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB CACNA1G | 1.19e-09 | 378 | 109 | 15 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC2A1 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB ABCD4 CACNA1G | 3.78e-09 | 550 | 109 | 17 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P KCNF1 GLRB ABCD4 CACNA1G | 1.31e-08 | 523 | 109 | 16 | GO:1902495 |
| GeneOntologyCellularComponent | calcium channel complex | 1.06e-07 | 73 | 109 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TRA CDH23 TRAC CHRNB1 TRBV29-1 SSPN KCNA2 KCNA3 KCNF1 GLRB ABCD4 CACNA1G C5 | 1.23e-07 | 785 | 109 | 18 | GO:0098797 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.38e-07 | 46 | 109 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR2 KCNA2 KCNA3 KCNF1 CACNA1G | 4.29e-07 | 235 | 109 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TRA CDH23 TRAC DPM2 CHRNB1 RYR2 TPCN1 TRBV29-1 SSPN KCNA2 KCNA3 CLCA3P KCNF1 GLRB ABCD4 CACNA1G C5 TAPBP | 6.15e-07 | 1498 | 109 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RNF121 FMO5 TPTE2 DCSTAMP WLS PIGV FADS2B DPM2 SLC39A13 RYR2 RETREG3 SGPP1 KCNA2 GUCY2C DERL3 TMCC2 CNIH1 ABCD4 KDSR SDR16C5 TAPBP | 2.86e-06 | 1293 | 109 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RNF121 FMO5 TPTE2 DCSTAMP WLS PIGV FADS2B DPM2 SLC39A13 RYR2 RETREG3 SGPP1 KCNA2 GUCY2C DERL3 TMCC2 CNIH1 ABCD4 KDSR SDR16C5 TAPBP | 3.08e-06 | 1299 | 109 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RNF121 FMO5 TPTE2 DCSTAMP WLS PIGV FADS2B DPM2 SLC39A13 RYR2 RETREG3 SGPP1 KCNA2 GUCY2C DERL3 TMCC2 CNIH1 ABCD4 KDSR SDR16C5 TAPBP | 4.29e-06 | 1327 | 109 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | Golgi membrane | RNF121 MGAT4B HS6ST2 TPTE2 WLS SLC2A1 UNC50 SLC39A13 GFY ABCA5 MANEAL CNIH1 TAPBP DOP1A | 2.31e-05 | 721 | 109 | 14 | GO:0000139 |
| GeneOntologyCellularComponent | sarcolemma | 6.26e-05 | 190 | 109 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | mannosyltransferase complex | 2.67e-04 | 5 | 109 | 2 | GO:0031501 | |
| GeneOntologyCellularComponent | apical part of cell | CHL1 CACNA1D SLC11A2 CDH23 SLC39A10 F2RL2 SLC2A1 SLC4A2 OPRPN GPIHBP1 UPK2 | 2.68e-04 | 592 | 109 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.72e-04 | 405 | 109 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 3.99e-04 | 6 | 109 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | endolysosome | 5.05e-04 | 30 | 109 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1C CACNA1D CACNA1E NTRK2 CHRNB1 SSPN KCNA2 KCNA3 GLRB FAIM2 | 9.47e-04 | 583 | 109 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | perikaryon | 1.12e-03 | 223 | 109 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | alpha-beta T cell receptor complex | 1.72e-03 | 12 | 109 | 2 | GO:0042105 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.72e-03 | 12 | 109 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | cell surface | CACNA1C CACNA1D SLC11A2 NTRK2 CP DCSTAMP RS1 AQP4 OPRPN GPIHBP1 GLRB FSHR CCR6 LTF | 1.90e-03 | 1111 | 109 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | lysosomal membrane | 2.91e-03 | 462 | 109 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.91e-03 | 462 | 109 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TPCN2 SLC11A2 ATR NTRK2 ENPP4 DCSTAMP WLS AQP4 SLC39A13 TPCN1 ABCA5 SLC15A4 CNIH1 ATM TAPBP | 3.21e-03 | 1307 | 109 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | TPCN2 SLC11A2 ATR NTRK2 ENPP4 DCSTAMP WLS AQP4 SLC39A13 TPCN1 ABCA5 SLC15A4 CNIH1 ATM TAPBP | 3.64e-03 | 1325 | 109 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | basal part of cell | 3.68e-03 | 378 | 109 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.00e-03 | 487 | 109 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | specific granule lumen | 4.17e-03 | 62 | 109 | 3 | GO:0035580 | |
| GeneOntologyCellularComponent | endosome membrane | 4.26e-03 | 602 | 109 | 9 | GO:0010008 | |
| GeneOntologyCellularComponent | endolysosome membrane | 4.81e-03 | 20 | 109 | 2 | GO:0036020 | |
| GeneOntologyCellularComponent | vacuolar membrane | 5.08e-03 | 507 | 109 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | early endosome membrane | 5.10e-03 | 212 | 109 | 5 | GO:0031901 | |
| Domain | Channel_four-helix_dom | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 TPCN1 KCNA2 KCNA3 KCNF1 CACNA1G | 1.84e-16 | 57 | 101 | 12 | IPR027359 |
| Domain | - | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 TPCN1 KCNA2 KCNA3 KCNF1 CACNA1G | 1.84e-16 | 57 | 101 | 12 | 1.20.120.350 |
| Domain | Ion_trans_dom | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 RYR2 TPCN1 KCNA2 KCNA3 KCNF1 CACNA1G | 4.22e-14 | 114 | 101 | 13 | IPR005821 |
| Domain | Ion_trans | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 RYR2 TPCN1 KCNA2 KCNA3 KCNF1 CACNA1G | 4.22e-14 | 114 | 101 | 13 | PF00520 |
| Domain | VDCCAlpha1 | 4.44e-12 | 10 | 101 | 6 | IPR002077 | |
| Domain | VDCC_a1su_IQ | 8.71e-11 | 7 | 101 | 5 | IPR014873 | |
| Domain | GPHH | 8.71e-11 | 7 | 101 | 5 | PF16905 | |
| Domain | GPHH_dom | 8.71e-11 | 7 | 101 | 5 | IPR031649 | |
| Domain | Ca_chan_IQ | 8.71e-11 | 7 | 101 | 5 | SM01062 | |
| Domain | Ca_chan_IQ | 8.71e-11 | 7 | 101 | 5 | PF08763 | |
| Domain | CAC1F_C | 1.53e-07 | 3 | 101 | 3 | IPR031688 | |
| Domain | CAC1F_C | 1.53e-07 | 3 | 101 | 3 | PF16885 | |
| Domain | VDCC_L_a1su | 6.12e-07 | 4 | 101 | 3 | IPR005446 | |
| Domain | Secretoglobin_1C1/2 | 2.90e-05 | 2 | 101 | 2 | IPR028659 | |
| Domain | FATC | 2.86e-04 | 5 | 101 | 2 | PF02260 | |
| Domain | Prot_inh_Kazal-m | 2.86e-04 | 5 | 101 | 2 | IPR001239 | |
| Domain | K_chnl_volt-dep_Kv | 4.09e-04 | 27 | 101 | 3 | IPR003968 | |
| Domain | FAT | 4.28e-04 | 6 | 101 | 2 | PS51189 | |
| Domain | FATC | 4.28e-04 | 6 | 101 | 2 | PS51190 | |
| Domain | FAT | 4.28e-04 | 6 | 101 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 4.28e-04 | 6 | 101 | 2 | IPR003151 | |
| Domain | FATC_dom | 4.28e-04 | 6 | 101 | 2 | IPR003152 | |
| Domain | PIK_FAT | 4.28e-04 | 6 | 101 | 2 | IPR014009 | |
| Domain | FATC | 4.28e-04 | 6 | 101 | 2 | SM01343 | |
| Domain | VG_K_chnl | 7.44e-04 | 33 | 101 | 3 | IPR028325 | |
| Domain | K_chnl_volt-dep_Kv1 | 7.94e-04 | 8 | 101 | 2 | IPR003972 | |
| Domain | MFS_dom | 8.05e-04 | 134 | 101 | 5 | IPR020846 | |
| Domain | SCGB | 1.02e-03 | 9 | 101 | 2 | PS51311 | |
| Domain | Uteroglobin | 1.27e-03 | 10 | 101 | 2 | PF01099 | |
| Domain | ABC_transporter_CS | 1.51e-03 | 42 | 101 | 3 | IPR017871 | |
| Domain | Secretoglobin | 1.54e-03 | 11 | 101 | 2 | IPR016126 | |
| Domain | ABC_A | 1.84e-03 | 12 | 101 | 2 | IPR026082 | |
| Domain | KAZAL | 1.97e-03 | 46 | 101 | 3 | SM00280 | |
| Domain | ABC_tran | 2.23e-03 | 48 | 101 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.23e-03 | 48 | 101 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.36e-03 | 49 | 101 | 3 | PS00211 | |
| Domain | KAZAL_2 | 2.50e-03 | 50 | 101 | 3 | PS51465 | |
| Domain | ABC_transporter-like | 2.50e-03 | 50 | 101 | 3 | IPR003439 | |
| Domain | Zip | 2.53e-03 | 14 | 101 | 2 | PF02535 | |
| Domain | ZIP | 2.53e-03 | 14 | 101 | 2 | IPR003689 | |
| Domain | Kazal_dom | 2.65e-03 | 51 | 101 | 3 | IPR002350 | |
| Domain | PI3/4_kinase_CS | 2.90e-03 | 15 | 101 | 2 | IPR018936 | |
| Domain | BTB_2 | 2.96e-03 | 53 | 101 | 3 | PF02214 | |
| Domain | T1-type_BTB | 2.96e-03 | 53 | 101 | 3 | IPR003131 | |
| Domain | LRRNT | 2.96e-03 | 53 | 101 | 3 | PF01462 | |
| Domain | ADH_SHORT | 2.96e-03 | 53 | 101 | 3 | PS00061 | |
| Domain | adh_short | 3.28e-03 | 55 | 101 | 3 | PF00106 | |
| Domain | - | 3.31e-03 | 16 | 101 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.31e-03 | 16 | 101 | 2 | SM00146 | |
| Domain | SDR_fam | 3.46e-03 | 56 | 101 | 3 | IPR002347 | |
| Domain | A/G_cyclase_CS | 3.73e-03 | 17 | 101 | 2 | IPR018297 | |
| Domain | PI3/4_kinase_cat_dom | 4.19e-03 | 18 | 101 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.19e-03 | 18 | 101 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.19e-03 | 18 | 101 | 2 | PS50290 | |
| Domain | Nucleotide_cyclase | 4.19e-03 | 18 | 101 | 2 | IPR029787 | |
| Domain | PI3_4_KINASE_1 | 4.19e-03 | 18 | 101 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.19e-03 | 18 | 101 | 2 | PS00916 | |
| Domain | KAZAL_1 | 4.19e-03 | 18 | 101 | 2 | PS00282 | |
| Domain | - | 4.19e-03 | 18 | 101 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.66e-03 | 19 | 101 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 4.66e-03 | 19 | 101 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.66e-03 | 19 | 101 | 2 | PS50125 | |
| Domain | A/G_cyclase | 4.66e-03 | 19 | 101 | 2 | IPR001054 | |
| Domain | CYCc | 4.66e-03 | 19 | 101 | 2 | SM00044 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.48e-09 | 23 | 84 | 6 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 6.04e-09 | 25 | 84 | 6 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.74e-08 | 6 | 84 | 4 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.75e-07 | 11 | 84 | 4 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TPCN2 SLC11A2 CP SLC39A10 SLCO1B1 AQP4 ABCA10 ADCY6 SLC2A1 RYR2 SLC4A2 TPCN1 GPIHBP1 SLC44A5 ABCA5 SLC15A4 DERL3 | 1.26e-06 | 736 | 84 | 17 | M27287 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.76e-06 | 42 | 84 | 5 | M7169 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 8.39e-06 | 47 | 84 | 5 | M19708 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.05e-05 | 61 | 84 | 5 | MM15071 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.57e-05 | 63 | 84 | 5 | M11187 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TPCN2 SLC11A2 CP SLCO1B1 AQP4 SLC2A1 RYR2 SLC4A2 TPCN1 GPIHBP1 SLC44A5 ABCA5 SLC15A4 DERL3 | 4.53e-05 | 681 | 84 | 14 | MM14985 |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 6.81e-05 | 72 | 84 | 5 | MM14631 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 7.09e-05 | 14 | 84 | 3 | M47692 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 9.09e-05 | 178 | 84 | 7 | M2890 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.00e-04 | 78 | 84 | 5 | M1921 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.16e-04 | 249 | 84 | 8 | M5988 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.97e-04 | 90 | 84 | 5 | M835 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.42e-04 | 147 | 84 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.79e-04 | 151 | 84 | 6 | M39329 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 3.77e-04 | 24 | 84 | 3 | M18795 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.59e-04 | 108 | 84 | 5 | M17034 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.38e-04 | 238 | 84 | 7 | MM15076 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 6.00e-04 | 28 | 84 | 3 | M10679 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 6.51e-04 | 177 | 84 | 6 | M27476 | |
| Pathway | WP_MAPK_SIGNALING | 6.54e-04 | 246 | 84 | 7 | M39597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT | 7.23e-04 | 7 | 84 | 2 | M47925 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 9.60e-04 | 8 | 84 | 2 | M22021 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 9.60e-04 | 8 | 84 | 2 | M42528 | |
| Pathway | BIOCARTA_PEPI_PATHWAY | 9.60e-04 | 8 | 84 | 2 | M22084 | |
| Pathway | WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES | 9.60e-04 | 8 | 84 | 2 | M45534 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 9.83e-04 | 74 | 84 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 9.83e-04 | 74 | 84 | 4 | M39462 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.06e-03 | 267 | 84 | 7 | M10792 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 1.23e-03 | 9 | 84 | 2 | M47586 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.26e-03 | 79 | 84 | 4 | M17673 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.51e-03 | 83 | 84 | 4 | M8728 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.53e-03 | 10 | 84 | 2 | M47572 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.58e-03 | 84 | 84 | 4 | M27334 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.85e-03 | 41 | 84 | 3 | MM14546 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.86e-03 | 11 | 84 | 2 | MM1501 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.86e-03 | 11 | 84 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.86e-03 | 11 | 84 | 2 | M26913 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.86e-03 | 11 | 84 | 2 | M15422 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 2.12e-03 | 43 | 84 | 3 | M39788 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 2.12e-03 | 43 | 84 | 3 | M1056 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.23e-03 | 12 | 84 | 2 | MM1526 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 2.23e-03 | 12 | 84 | 2 | M7772 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.27e-03 | 44 | 84 | 3 | M11911 | |
| Pubmed | 5.76e-12 | 7 | 109 | 5 | 12900400 | ||
| Pubmed | 1.53e-11 | 8 | 109 | 5 | 28330839 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR2 KCNA2 KCNA3 KCNF1 CACNA1G | 2.28e-11 | 139 | 109 | 10 | 16985003 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.85e-11 | 38 | 109 | 7 | 30786075 | |
| Pubmed | 3.44e-11 | 9 | 109 | 5 | 16382099 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 11296258 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 15451373 | ||
| Pubmed | 8.07e-10 | 15 | 109 | 5 | 20188150 | ||
| Pubmed | 8.07e-10 | 15 | 109 | 5 | 24453333 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 20937870 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 2.11e-07 | 17 | 109 | 4 | 27725084 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 31663850 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 12060068 | ||
| Pubmed | 3.60e-07 | 143 | 109 | 7 | 20424473 | ||
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 5.95e-07 | 6 | 109 | 3 | 16029198 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A5 MGAT4B ATR HS6ST2 SLC39A10 WLS SLC39A13 SLC4A2 TPCN1 MANEAL RRP12 SLPI ATM KDSR TAPBP SPINK6 | 1.08e-06 | 1201 | 109 | 16 | 35696571 |
| Pubmed | 3.07e-06 | 32 | 109 | 4 | 19320717 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | SLC12A8 WLS ADCY6 SLC2A1 RETREG3 SLC4A2 SLC15A4 SLC49A4 KDSR TAPBP | 4.05e-06 | 499 | 109 | 10 | 22810586 |
| Pubmed | 4.85e-06 | 11 | 109 | 3 | 18809727 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 5.57e-06 | 37 | 109 | 4 | 25798587 | |
| Pubmed | Heart neurons use clock genes to control myocyte proliferation. | 5.57e-06 | 37 | 109 | 4 | 34851661 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 38892470 | ||
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 9.73e-06 | 2 | 109 | 2 | 19285939 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18285402 | ||
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 9.73e-06 | 2 | 109 | 2 | 37338595 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28851706 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15610184 | ||
| Pubmed | Expression of Ca²⁺-permeable two-pore channels rescues NAADP signalling in TPC-deficient cells. | 9.73e-06 | 2 | 109 | 2 | 25872774 | |
| Pubmed | The voltage-gated sodium channel TPC1 confers endolysosomal excitability. | 9.73e-06 | 2 | 109 | 2 | 24776928 | |
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 9.73e-06 | 2 | 109 | 2 | 34151669 | |
| Pubmed | Endolysosomal two-pore channels regulate autophagy in cardiomyocytes. | 9.73e-06 | 2 | 109 | 2 | 26757341 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21054386 | ||
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 9.73e-06 | 2 | 109 | 2 | 16213462 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30482851 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27442013 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24726882 | ||
| Pubmed | Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling. | 9.73e-06 | 2 | 109 | 2 | 19620632 | |
| Pubmed | Structural characterization of the ceruloplasmin: lactoferrin complex in solution. | 9.73e-06 | 2 | 109 | 2 | 17597152 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 34353321 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 9.73e-06 | 2 | 109 | 2 | 25966695 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26061708 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25722412 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20103595 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11908641 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24086669 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25157141 | ||
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 9.73e-06 | 2 | 109 | 2 | 17934520 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 9.73e-06 | 2 | 109 | 2 | 23592994 | |
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 9.73e-06 | 2 | 109 | 2 | 26049024 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19527713 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 9.73e-06 | 2 | 109 | 2 | 16706838 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10666301 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23761887 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 38069040 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14981074 | ||
| Pubmed | Unexpected Motherhood-Triggered Hearing Loss in the Two-Pore Channel (TPC) Mutant Mouse. | 9.73e-06 | 2 | 109 | 2 | 35885013 | |
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 9.73e-06 | 2 | 109 | 2 | 25292336 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17526649 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26567218 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12606379 | ||
| Pubmed | The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release. | 9.73e-06 | 2 | 109 | 2 | 18264801 | |
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 9.73e-06 | 2 | 109 | 2 | 24941892 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25545384 | ||
| Pubmed | A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. | 9.73e-06 | 2 | 109 | 2 | 24699711 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25135478 | ||
| Pubmed | Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection. | 9.73e-06 | 2 | 109 | 2 | 22748467 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22826131 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33742106 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 9.73e-06 | 2 | 109 | 2 | 16921373 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24470632 | ||
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 9.73e-06 | 2 | 109 | 2 | 33887296 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 9.73e-06 | 2 | 109 | 2 | 10691732 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31114877 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35011623 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24760982 | ||
| Pubmed | Organelle-specific subunit interactions of the vertebrate two-pore channel family. | 9.73e-06 | 2 | 109 | 2 | 25451935 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26517239 | ||
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 9.73e-06 | 2 | 109 | 2 | 33034621 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26152717 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20014384 | ||
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 9.73e-06 | 2 | 109 | 2 | 21593482 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25232030 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24068928 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26152696 | ||
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 9.73e-06 | 2 | 109 | 2 | 18757420 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11927575 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28820634 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29279380 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12526805 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12973680 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30001160 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21352396 | ||
| Pubmed | Expression and chromosomal localization of a lymphocyte K+ channel gene. | 9.73e-06 | 2 | 109 | 2 | 2251283 | |
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 9.73e-06 | 2 | 109 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 9.73e-06 | 2 | 109 | 2 | 16267232 | |
| Pubmed | Structural mechanisms of phospholipid activation of the human TPC2 channel. | 9.73e-06 | 2 | 109 | 2 | 30860481 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33144668 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19470682 | ||
| Interaction | TTYH1 interactions | TPCN2 ADCY6 RETREG3 SLC4A2 TPCN1 SLC44A5 MANEAL GLRB ABCD4 TMEM143 | 2.93e-06 | 300 | 102 | 10 | int:TTYH1 |
| Interaction | CACNA1D interactions | 6.08e-06 | 24 | 102 | 4 | int:CACNA1D | |
| Interaction | LPAR1 interactions | 1.15e-05 | 210 | 102 | 8 | int:LPAR1 | |
| Interaction | C5AR1 interactions | 1.34e-05 | 154 | 102 | 7 | int:C5AR1 | |
| Interaction | EOGT interactions | 1.68e-05 | 63 | 102 | 5 | int:EOGT | |
| Interaction | CACNA1B interactions | 3.59e-05 | 37 | 102 | 4 | int:CACNA1B | |
| Interaction | SCN11A interactions | 5.48e-05 | 15 | 102 | 3 | int:SCN11A | |
| Interaction | TSPAN15 interactions | 8.07e-05 | 276 | 102 | 8 | int:TSPAN15 | |
| Interaction | OPRM1 interactions | 9.19e-05 | 144 | 102 | 6 | int:OPRM1 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.23e-09 | 26 | 79 | 6 | 253 | |
| GeneFamily | Solute carriers | SLC11A2 SLC12A8 SLC39A10 SLCO1B1 SLC2A1 SLC39A13 SLC4A2 SLC44A5 SLC15A4 SLC49A4 | 8.32e-06 | 395 | 79 | 10 | 752 |
| GeneFamily | Two pore segment channels | 1.89e-05 | 2 | 79 | 2 | 247 | |
| GeneFamily | Olfactory receptors, family 56 | 6.65e-04 | 9 | 79 | 2 | 167 | |
| GeneFamily | Potassium voltage-gated channels | 7.06e-04 | 40 | 79 | 3 | 274 | |
| GeneFamily | Serine peptidase inhibitors, Kazal type | 8.29e-04 | 10 | 79 | 2 | 740 | |
| GeneFamily | Secretoglobins | 1.66e-03 | 14 | 79 | 2 | 734 | |
| GeneFamily | ATP binding cassette subfamily A | 1.66e-03 | 14 | 79 | 2 | 805 | |
| GeneFamily | Endogenous ligands | 3.81e-03 | 237 | 79 | 5 | 542 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 4.49e-03 | 76 | 79 | 3 | 743 | |
| Coexpression | GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.60e-06 | 169 | 108 | 7 | M9087 | |
| Coexpression | GSE12366_NAIVE_VS_MEMORY_BCELL_DN | 1.57e-05 | 193 | 108 | 7 | M3181 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | RNF121 COL4A5 TPCN2 SLC11A2 SLC39A10 ADCY6 SLC2A1 UNC50 SLC39A13 SGPP1 SLC49A4 KDSR | 2.46e-05 | 681 | 108 | 12 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | RNF121 COL4A5 TPCN2 SLC11A2 SLC39A10 ADCY6 SLC2A1 UNC50 SLC39A13 SGPP1 SLC49A4 KDSR | 3.36e-05 | 703 | 108 | 12 | MM1055 |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 5.98e-05 | 163 | 108 | 6 | M2997 | |
| Coexpression | QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP | 6.28e-05 | 19 | 108 | 3 | M40969 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 6.62e-05 | 166 | 108 | 6 | M39026 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_200 | 1.19e-06 | 18 | 97 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_100 | 1.53e-06 | 78 | 97 | 6 | gudmap_developingLowerUrinaryTract_adult_ureter_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_200 | 5.51e-06 | 149 | 97 | 7 | gudmap_developingLowerUrinaryTract_adult_ureter_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.38e-06 | 59 | 97 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#5_top-relative-expression-ranked_500 | 1.17e-05 | 31 | 97 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#1_top-relative-expression-ranked_100 | 2.56e-05 | 13 | 97 | 3 | gudmap_developingLowerUrinaryTract_adult_ureter_100_k1 | |
| CoexpressionAtlas | BM Top 100 - salivary gland | 3.29e-05 | 80 | 97 | 5 | BM Top 100 - salivary gland | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#5_top-relative-expression-ranked_500 | 1.01e-04 | 53 | 97 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 1.16e-04 | 21 | 97 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000 | CHL1 FMO5 SPINK1 CP ENPP4 SGPP1 OPRPN VANGL1 ODAM LTF CXCL8 CA6 | 1.32e-04 | 736 | 97 | 12 | gudmap_developingLowerUrinaryTract_adult_ureter_1000 |
| CoexpressionAtlas | cerebral cortex | CHL1 CACNA1B CACNA1E NTRK2 SLC39A10 HSD11B1L RS1 AQP4 OMG KCNA2 KCNF1 MANEAL TMEM145 TMCC2 GLRB CACNA1G FAIM2 | 2.37e-04 | 1428 | 97 | 17 | cerebral cortex |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 4.77e-07 | 192 | 109 | 7 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-07 | 195 | 109 | 7 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.67e-07 | 197 | 109 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 5.86e-07 | 198 | 109 | 7 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.84e-07 | 126 | 109 | 6 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.84e-07 | 126 | 109 | 6 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 155 | 109 | 6 | 8dab23aad905cc35a35643baa0554acb3f6fe6c8 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 155 | 109 | 6 | 42533beaded07068f00540de704de07e4f19abcf | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 157 | 109 | 6 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 161 | 109 | 6 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | facs-Heart-LV-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 163 | 109 | 6 | 648d5439811b64412bc4678646f216105b90b9a1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.18e-06 | 172 | 109 | 6 | 5401ac7739f95fb8681cfb4747ab6e447a3c2ae8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.18e-06 | 172 | 109 | 6 | b3da7f488d191214d7bb74fbac189fe8c29ee6cd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.18e-06 | 172 | 109 | 6 | 74dd4a7acb2cf857fed20219e4d7dc1adfbaa398 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.47e-06 | 174 | 109 | 6 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.35e-06 | 106 | 109 | 5 | d8868c10785e52a1c22c91e1d0e208f2070393bb | |
| ToppCell | -IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.35e-06 | 185 | 109 | 6 | 10f7e5daf8e95dda9453212e84b64874f4e0d7ab | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.85e-06 | 192 | 109 | 6 | a22952b885c8a7704a4a9602fa03e4f2c786bf75 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.85e-06 | 192 | 109 | 6 | dcf2d0c2e8868104c4dba410456207f0d947029a | |
| ToppCell | COPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 8.33e-06 | 194 | 109 | 6 | 72a2e0cba171ab59aa176e91a59a54c562af0390 | |
| ToppCell | C_06|World / shred on cell type and cluster | 8.33e-06 | 194 | 109 | 6 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | 18-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 8.33e-06 | 194 | 109 | 6 | 9a2efa50731135a178141aae55fa8b3e022c9904 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-06 | 195 | 109 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.67e-06 | 113 | 109 | 5 | b795a0c65114b3c0758fe3720e8a80247f900971 | |
| ToppCell | COVID-19_Mild-Myeloid_G-immature_Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 8.67e-06 | 113 | 109 | 5 | fc3417c379f871a4aec3edef953baaa00755c472 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.83e-06 | 196 | 109 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.05e-06 | 114 | 109 | 5 | 613714fd15ad6d553e63d8538ad53bc1ded6bd6c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.09e-06 | 197 | 109 | 6 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.36e-06 | 198 | 109 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 198 | 109 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.36e-06 | 198 | 109 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.36e-06 | 198 | 109 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.36e-06 | 198 | 109 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | a8bfc0b93ad9968cf52a25be86995ffe436bd636 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-06 | 199 | 109 | 6 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.63e-06 | 199 | 109 | 6 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.63e-06 | 199 | 109 | 6 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.63e-06 | 199 | 109 | 6 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.63e-06 | 199 | 109 | 6 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.63e-06 | 199 | 109 | 6 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Serous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | e9908b6cba21a59023cf8d0f98fbd1d1f7de6b44 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.FIbcd1-Inhba_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 65 | 109 | 4 | 5fc678ea0490cbcfe00d569727b97ccba3a19232 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 148 | 109 | 5 | 941bad657064b3d37cae8b66df99c1aa1098c088 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 3.30e-05 | 149 | 109 | 5 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.74e-05 | 153 | 109 | 5 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 157 | 109 | 5 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 157 | 109 | 5 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.50e-05 | 159 | 109 | 5 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 160 | 109 | 5 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 160 | 109 | 5 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 161 | 109 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 161 | 109 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-05 | 161 | 109 | 5 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.77e-05 | 161 | 109 | 5 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 162 | 109 | 5 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 165 | 109 | 5 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 165 | 109 | 5 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 165 | 109 | 5 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.52e-05 | 166 | 109 | 5 | d16af6570806ed2880bd0efb5298932fd2a89cf5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.52e-05 | 166 | 109 | 5 | 139bf49eb3624d9eec7e8a2cb33d69716d63a7c5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.52e-05 | 166 | 109 | 5 | 85f59c3cc7db8863ec0044f1fcc14580834f830b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-05 | 166 | 109 | 5 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.68e-05 | 167 | 109 | 5 | 8ec7a98b542b134f48df8fbec351693cc5cfe55c | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.68e-05 | 167 | 109 | 5 | a9f28c4649ce344ae3ba3a3acb58da9c7efad901 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | 41da200bbff5c663c39f67c38d6d5f43b0ad9494 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | a77259c13508f19186d7b0f80b34dc6d89497ab5 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | e348d9877a1bcad4f33dd7b2ce6cb0049583c4d2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 3167ca0c826244280e0e07d1e02656cf5e4e75a5 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | 2dcc9d67d6ecc35940eabbc8ed528f5f884f6976 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | 64d2edbd8e2640b76225597883b1a524e6b1dd3b | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | d061ea21bee179df5a525842e9a48621a8e1461b | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 173 | 109 | 5 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | c92eec5a14ca5269673582dd115ead8516e64c3e | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.28e-05 | 176 | 109 | 5 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.47e-05 | 177 | 109 | 5 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.47e-05 | 177 | 109 | 5 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-05 | 177 | 109 | 5 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | 40bd605b801d9ae76cffc8f62836092fc2b06812 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 109 | 5 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.88e-05 | 179 | 109 | 5 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.09e-05 | 180 | 109 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-05 | 181 | 109 | 5 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.30e-05 | 181 | 109 | 5 | bab282cb0d9fc049f6fb094cf8b1fba104f4ea17 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 8.30e-05 | 181 | 109 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.30e-05 | 181 | 109 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.97e-05 | 184 | 109 | 5 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.20e-05 | 185 | 109 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.44e-05 | 186 | 109 | 5 | 189b75aa98903f1cb65b624524ba6c30df7e42ff | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 9.44e-05 | 186 | 109 | 5 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.44e-05 | 186 | 109 | 5 | 261891d0b148e285339ae0b9e36136ceabd9b6f5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.19e-06 | 50 | 57 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.36e-04 | 50 | 57 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED | |
| Drug | lanthanum | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 TPTE2 CDH23 ADCY6 RYR2 TPCN1 GUCY2C CACNA1G | 6.01e-14 | 136 | 105 | 13 | CID000023926 |
| Drug | verapamil | CACNA1B CACNA1C COL4A5 CACNA1D CACNA1E CACNA1F TPCN2 SLCO1B1 ABCA10 ADCY6 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 ABCA5 KCNF1 ABCD4 CACNA1G | 9.94e-13 | 490 | 105 | 19 | CID000002520 |
| Drug | Cinildipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 4.21e-12 | 56 | 105 | 9 | CID000002752 |
| Drug | nilvadipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 8.09e-12 | 60 | 105 | 9 | CID000004494 |
| Drug | lercanidipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 1.28e-11 | 63 | 105 | 9 | CID000065866 |
| Drug | gallopamil | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 2.28e-11 | 67 | 105 | 9 | CID000001234 |
| Drug | AC1L2AC7 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 3.00e-11 | 69 | 105 | 9 | CID000068733 |
| Drug | CAS 298-57-7 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 5.06e-11 | 73 | 105 | 9 | CID000002761 |
| Drug | ethosuximide | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 5.73e-11 | 74 | 105 | 9 | CID000003291 |
| Drug | NSC759576 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLCO1B1 AQP4 ADCY6 RYR2 TPCN1 CACNA1G | 8.49e-11 | 191 | 105 | 12 | CID000003075 |
| Drug | nisoldipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 9.32e-11 | 78 | 105 | 9 | CID000004499 |
| Drug | CNS 1145 | 1.40e-10 | 33 | 105 | 7 | CID000190902 | |
| Drug | IHC-64 | 1.40e-10 | 33 | 105 | 7 | CID000162753 | |
| Drug | IAA-94 | 3.75e-10 | 61 | 105 | 8 | CID000003667 | |
| Drug | phenytoin | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC2A1 RYR2 TPCN1 KCNA2 KCNA3 CACNA1G | 4.13e-10 | 219 | 105 | 12 | CID000001775 |
| Drug | manidipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 5.63e-10 | 95 | 105 | 9 | CID000004008 |
| Drug | nitrendipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 7.45e-10 | 98 | 105 | 9 | CID000004507 |
| Drug | isradipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 8.94e-10 | 100 | 105 | 9 | CID000003784 |
| Drug | nicardipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 CACNA1G | 1.38e-09 | 145 | 105 | 10 | CID000004473 |
| Drug | Dantrolene-13C3 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G CA6 | 1.38e-09 | 145 | 105 | 10 | CID000002951 |
| Drug | loperamide | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 1.39e-09 | 105 | 105 | 9 | CID000003954 |
| Drug | Bay K 8644 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 ADCY6 RYR2 TPCN1 CACNA1G | 1.92e-09 | 150 | 105 | 10 | CID000002303 |
| Drug | procaine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 CACNA1G | 2.33e-09 | 153 | 105 | 10 | CID000004914 |
| Drug | lamotrigine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 3.37e-09 | 116 | 105 | 9 | CID000003878 |
| Drug | AC1NBU2S | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR2 GUCY2C CACNA1G CXCL8 | 3.64e-09 | 117 | 105 | 9 | CID004473765 |
| Drug | bepridil | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 7.01e-09 | 126 | 105 | 9 | CID000002351 |
| Drug | pimozide | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 7.52e-09 | 127 | 105 | 9 | CID000016362 |
| Drug | Verapamil | 7.95e-09 | 16 | 105 | 5 | DB00661 | |
| Drug | dihydropyridine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 SSPN CACNA1G | 2.18e-08 | 193 | 105 | 10 | CID000104822 |
| Drug | AC1L1TJF | 2.26e-08 | 66 | 105 | 7 | CID000003377 | |
| Drug | halothane | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 ADCY6 CHRNB1 RYR2 TPCN1 GLRB CACNA1G | 2.39e-08 | 314 | 105 | 12 | CID000003562 |
| Drug | nimodipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 2.40e-08 | 145 | 105 | 9 | CID000004497 |
| Drug | Cinnarizine | 5.29e-08 | 9 | 105 | 4 | DB00568 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 8.00e-08 | 79 | 105 | 7 | CID005287890 | |
| Drug | U46619 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F IL17F ADCY6 RYR2 GUCY2C CACNA1G CXCL8 | 8.57e-08 | 285 | 105 | 11 | CID000005618 |
| Drug | gabapentin | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 9.02e-08 | 169 | 105 | 9 | CID000003446 |
| Drug | felodipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 RYR2 TPCN1 CACNA1G | 9.02e-08 | 169 | 105 | 9 | CID000003333 |
| Drug | lavendustin A | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR2 KCNA3 GLRB CACNA1G | 9.98e-08 | 171 | 105 | 9 | CID000003894 |
| Drug | papaverine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F ADCY6 RYR2 GUCY2C CACNA1G | 1.28e-07 | 176 | 105 | 9 | CID000004680 |
| Drug | Mibefradil | 1.37e-07 | 11 | 105 | 4 | DB01388 | |
| Drug | potassium | CACNA1B CACNA1C COL4A5 CACNA1D CACNA1E CACNA1F TPCN2 SLC12A8 AQP4 ADCY6 CHRNB1 RYR2 TPCN1 KCNA2 KCNA3 CLCA3P GUCY2C KCNF1 CACNA1G | 1.59e-07 | 1008 | 105 | 19 | CID000000813 |
| Drug | NSC7524 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F ADCY6 CHRNB1 RYR2 CACNA1G | 1.70e-07 | 182 | 105 | 9 | CID000005657 |
| Drug | AC1NUZ8M | 2.30e-07 | 92 | 105 | 7 | CID000073211 | |
| Drug | nickel | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 ADCY6 RYR2 TPCN1 CACNA1G KDSR CXCL8 CA6 | 2.50e-07 | 552 | 105 | 14 | CID000000934 |
| Drug | cobalt-60 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 CP ADCY6 RYR2 TPCN1 CACNA1G | 2.51e-07 | 390 | 105 | 12 | CID000061492 |
| Drug | baclofen | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F ADCY6 RYR2 GLRB CACNA1G | 2.56e-07 | 191 | 105 | 9 | CID000002284 |
| Drug | gamma-aminobutyric acid | CACNA1B CACNA1C COL4A5 CACNA1D CACNA1E CACNA1F NTRK2 CHRNB1 RYR2 CLCA3P GLRB CACNA1G PSPN | 2.87e-07 | 474 | 105 | 13 | CID000000119 |
| Drug | isotetrandrine | 3.31e-07 | 97 | 105 | 7 | CID000005422 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 NTRK2 SLC2A1 CHRNB1 RYR2 TPCN1 GUCY2C GLRB CACNA1G CXCL8 | 3.31e-07 | 655 | 105 | 15 | CID000004376 |
| Drug | isovalerate | 3.32e-07 | 143 | 105 | 8 | CID000010430 | |
| Drug | pyraclofos | 6.07e-07 | 106 | 105 | 7 | CID000093460 | |
| Drug | cyclophorine | CACNA1B CACNA1C COL4A5 CACNA1D CACNA1E CACNA1F SLCO1B1 AQP4 ADCY6 RYR2 CACNA1G CXCL8 | 6.41e-07 | 426 | 105 | 12 | CID000002909 |
| Drug | Barium | 1.02e-06 | 72 | 105 | 6 | ctd:D001464 | |
| Drug | AC1L1KC5 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 CHRNB1 RYR2 TPCN1 KCNA3 SLC49A4 CACNA1G CXCL8 | 1.27e-06 | 541 | 105 | 13 | CID000005428 |
| Drug | riluzole | 1.47e-06 | 174 | 105 | 8 | CID000005070 | |
| Drug | glibenclamide | CACNA1C CACNA1D ABCA10 ADCY6 KCNA2 KCNA3 CLCA3P ABCA5 GUCY2C ABCD4 CXCL8 | 1.56e-06 | 382 | 105 | 11 | CID000003488 |
| Drug | 3,4-dihydroquinazoline | 1.89e-06 | 6 | 105 | 3 | CID000583065 | |
| Drug | Calcium | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CP SLC2A1 RYR2 GIP CACNA1G C5 CXCL8 | 2.93e-06 | 493 | 105 | 12 | ctd:D002118 |
| Drug | 4-AP | CACNA1B CACNA1C CACNA1D CACNA1E IL17F KCNA2 KCNA3 GUCY2C KCNF1 | 3.12e-06 | 258 | 105 | 9 | CID000001727 |
| Drug | Amlodipine | 3.29e-06 | 7 | 105 | 3 | DB00381 | |
| Drug | carbachol | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 ADCY6 CHRNB1 RYR2 TPCN1 GIP GUCY2C CACNA1G MMP8 | 3.37e-06 | 688 | 105 | 14 | CID000002551 |
| Drug | AC1L1KS5 | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F ADCY6 RYR2 CACNA1G CCR6 CXCL8 | 3.39e-06 | 334 | 105 | 10 | CID000005631 |
| Drug | KW-3049 | 3.40e-06 | 50 | 105 | 5 | CID000002324 | |
| Drug | manganese | CACNA1B CACNA1C COL4A5 CACNA1D CACNA1E CACNA1F SLC11A2 CP IL17F ADCY6 CHRNB1 RYR2 GUCY2C CACNA1G LTF | 3.45e-06 | 791 | 105 | 15 | CID000023930 |
| Drug | nifedipine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 SLC11A2 RYR2 TPCN1 KCNA2 CACNA1G | 3.47e-06 | 415 | 105 | 11 | CID000004485 |
| Drug | gadolinium | 4.00e-06 | 199 | 105 | 8 | CID000023982 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 4.15e-06 | 200 | 105 | 8 | 409_DN | |
| Drug | atropine sulfate | CACNA1B CACNA1E SPINK1 CP ADCY6 CHRNB1 GIP CLCA3P GUCY2C LTF | 4.76e-06 | 347 | 105 | 10 | CID000003661 |
| Drug | ethanol | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SPINK1 NTRK2 ADCY6 SLC2A1 CHRNB1 GLRB FSHR LTF CXCL8 CA6 | 6.82e-06 | 837 | 105 | 15 | CID000000702 |
| Drug | Nimodipine | 7.85e-06 | 9 | 105 | 3 | DB00393 | |
| Drug | glutamate | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F NTRK2 AQP4 ADCY6 SLC2A1 CHRNB1 RYR2 SLC4A2 KCNA2 CLCA3P GLRB CACNA1G | 8.36e-06 | 962 | 105 | 16 | CID000000611 |
| Drug | caffeine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPCN2 ADCY6 CHRNB1 RYR2 TPCN1 CACNA1G ATM | 1.10e-05 | 562 | 105 | 12 | CID000002519 |
| Drug | mibefradil | 1.16e-05 | 64 | 105 | 5 | CID000060662 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F ADCY6 RYR2 GUCY2C CACNA1G | 1.30e-05 | 308 | 105 | 9 | CID000001915 |
| Drug | benzilate | 1.35e-05 | 66 | 105 | 5 | CID000201538 | |
| Drug | noradrealine | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F IL17F ADCY6 RYR2 GIP CACNA1G MMP8 CXCL8 | 1.38e-05 | 575 | 105 | 12 | CID000000951 |
| Drug | amiloride | CACNA1B CACNA1C CACNA1D TPCN2 CHRNB1 SLC4A2 TPCN1 GLRB CXCL8 | 1.56e-05 | 315 | 105 | 9 | CID000016230 |
| Drug | NiCl2 | 1.90e-05 | 119 | 105 | 6 | CID000024385 | |
| Drug | AC1L2VU3 | 2.03e-05 | 12 | 105 | 3 | CID000129572 | |
| Drug | aristolactam AII | 2.11e-05 | 2 | 105 | 2 | CID000148657 | |
| Drug | alkosin | 2.11e-05 | 2 | 105 | 2 | CID005488638 | |
| Drug | norcepharadione B | 2.11e-05 | 2 | 105 | 2 | CID000189168 | |
| Drug | piperolactam A | 2.11e-05 | 2 | 105 | 2 | CID003081016 | |
| Drug | 1-EBIO | 2.51e-05 | 37 | 105 | 4 | CID000082320 | |
| Drug | Deferoxamine | 2.51e-05 | 186 | 105 | 7 | ctd:D003676 | |
| Drug | amlodipine | 2.62e-05 | 126 | 105 | 6 | CID000002162 | |
| Drug | sodium | CACNA1C CACNA1D CP SLC12A8 SLCO1B1 ADCY6 SLC2A1 RYR2 SLC4A2 TPCN1 KCNA2 KCNA3 GUCY2C LTF CXCL8 | 2.80e-05 | 944 | 105 | 15 | CID000000923 |
| Drug | enzacamene | 2.99e-05 | 129 | 105 | 6 | ctd:C038939 | |
| Drug | propranolol | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F IL17F ADCY6 CHRNB1 RYR2 CACNA1G | 3.28e-05 | 434 | 105 | 10 | CID000004946 |
| Drug | AC1L1JG6 | 3.34e-05 | 14 | 105 | 3 | CID000005026 | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 4407_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.00e-05 | 200 | 105 | 7 | 4824_DN | |
| Drug | butamben | 4.17e-05 | 15 | 105 | 3 | CID000002482 | |
| Drug | FPL 64176 | 4.17e-05 | 15 | 105 | 3 | CID000003423 | |
| Drug | octylmethoxycinnamate | 4.55e-05 | 139 | 105 | 6 | ctd:C118580 | |
| Drug | pentasulfane | 5.11e-05 | 16 | 105 | 3 | CID000448216 | |
| Drug | h PM | 5.50e-05 | 45 | 105 | 4 | CID005494424 | |
| Drug | tetrabromobisphenol A | CDH23 F2RL2 SLCO1B1 GIP KCNA2 VANGL1 RRP12 SLPI CACNA1G LTF FAIM2 CXCL8 CA6 SCGB1C1 | 5.99e-05 | 891 | 105 | 14 | ctd:C020806 |
| Drug | AC1Q1NVI | 6.30e-05 | 3 | 105 | 2 | CID006439529 | |
| Drug | valproate | CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR2 TPCN1 GLRB CACNA1G | 6.84e-05 | 381 | 105 | 9 | CID000003121 |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.65e-07 | 4 | 103 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 1.21e-05 | 2 | 103 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | CACNA1C CACNA1D CACNA1E NTRK2 CDH23 OMG SLC39A13 RYR2 GIP RRP12 CACNA1G MFSD13A | 1.48e-05 | 764 | 103 | 12 | EFO_0008579 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 6.95e-05 | 23 | 103 | 3 | C0021051 | |
| Disease | migraine (implicated_via_orthology) | 7.21e-05 | 4 | 103 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | lactotransferrin measurement | 7.21e-05 | 4 | 103 | 2 | EFO_0020526 | |
| Disease | Dystonia | 2.39e-04 | 86 | 103 | 4 | C0013421 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.51e-04 | 7 | 103 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.71e-04 | 36 | 103 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.74e-04 | 163 | 103 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy | 3.09e-04 | 92 | 103 | 4 | EFO_0000538 | |
| Disease | Diarrhea | 6.50e-04 | 11 | 103 | 2 | C0011991 | |
| Disease | Hereditary hemochromatosis | 7.78e-04 | 12 | 103 | 2 | C0392514 | |
| Disease | Hemochromatosis | 7.78e-04 | 12 | 103 | 2 | C0018995 | |
| Disease | Colorectal Carcinoma | 7.98e-04 | 702 | 103 | 9 | C0009402 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0800474 | |
| Disease | Seizures | 1.02e-03 | 218 | 103 | 5 | C0036572 | |
| Disease | Pneumoconiosis | 1.07e-03 | 14 | 103 | 2 | C0032273 | |
| Disease | Bagassosis | 1.07e-03 | 14 | 103 | 2 | C0004681 | |
| Disease | brain edema (biomarker_via_orthology) | 1.23e-03 | 15 | 103 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Tremor, Rubral | 1.40e-03 | 16 | 103 | 2 | C0750940 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.40e-03 | 16 | 103 | 2 | EFO_0008297 | |
| Disease | Ataxia, Appendicular | 1.40e-03 | 16 | 103 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.40e-03 | 16 | 103 | 2 | C0278161 | |
| Disease | pancreatitis | 1.40e-03 | 16 | 103 | 2 | EFO_0000278 | |
| Disease | Ataxia, Sensory | 1.40e-03 | 16 | 103 | 2 | C0240991 | |
| Disease | Abnormal coordination | 1.40e-03 | 16 | 103 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.40e-03 | 16 | 103 | 2 | C0427190 | |
| Disease | Ulcerative Colitis | 1.41e-03 | 63 | 103 | 3 | C0009324 | |
| Disease | Profound Mental Retardation | 1.45e-03 | 139 | 103 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.45e-03 | 139 | 103 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.45e-03 | 139 | 103 | 4 | C0917816 | |
| Disease | Inborn Errors of Metabolism | 1.59e-03 | 17 | 103 | 2 | C0025521 | |
| Disease | Benign neoplasm of stomach | 1.59e-03 | 17 | 103 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.59e-03 | 17 | 103 | 2 | C0496905 | |
| Disease | Antibody Deficiency Syndrome | 1.59e-03 | 17 | 103 | 2 | C0003257 | |
| Disease | Carcinoma in situ of stomach | 1.59e-03 | 17 | 103 | 2 | C0154060 | |
| Disease | Manic Disorder | 1.99e-03 | 71 | 103 | 3 | C0024713 | |
| Disease | Stomach Carcinoma | 2.43e-03 | 21 | 103 | 2 | C0699791 | |
| Disease | asparaginase hypersensitivity | 2.51e-03 | 77 | 103 | 3 | EFO_0004881 | |
| Disease | Manic | 2.60e-03 | 78 | 103 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 2.69e-03 | 79 | 103 | 3 | C0005587 | |
| Disease | Colorectal Neoplasms | 2.91e-03 | 277 | 103 | 5 | C0009404 | |
| Disease | Anhedonia | 3.17e-03 | 24 | 103 | 2 | C0178417 | |
| Disease | Hepatolenticular Degeneration | 3.17e-03 | 24 | 103 | 2 | C0019202 | |
| Disease | Hepatic Form of Wilson Disease | 3.17e-03 | 24 | 103 | 2 | C1527352 | |
| Disease | endometriosis (is_marker_for) | 3.44e-03 | 25 | 103 | 2 | DOID:289 (is_marker_for) | |
| Disease | response to gemcitabine | 3.44e-03 | 25 | 103 | 2 | GO_0036272 | |
| Disease | Ataxia | 3.44e-03 | 25 | 103 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLFISMAFKLLILLI | 151 | Q8TAA9 | |
| LFFIILILMLGSLLA | 1076 | Q8WWZ7 | |
| EFLAMLIFVLLSLGS | 41 | P55087 | |
| VFLALLMVALEGSFL | 801 | P04920 | |
| LLQIGLLLFFAILMF | 221 | Q15878 | |
| LLLFFAILMFAIIGL | 226 | Q15878 | |
| LLLFVGLFISYVMLK | 61 | O94777 | |
| GLSLIALAFLMSVLI | 221 | Q8WWZ4 | |
| IGKLAMIFVLGLIYL | 836 | O43306 | |
| LALGGFLTMIILTLK | 181 | Q9UPC5 | |
| KLLMLGLELLFGFFI | 211 | P51684 | |
| MDKVQSGFLILFLFL | 1 | Q8NEA5 | |
| KMGLSIFALLTLTVF | 276 | P11230 | |
| MLLKRLAFAIFSSEI | 2176 | Q5JWR5 | |
| MVATKTFALLLLSLF | 1 | P09681 | |
| LEGFKTLTFLAVMLI | 76 | O14678 | |
| MKVLLLTGLGALFFA | 1 | Q7Z5J1 | |
| VLMTLLGLLGSLFFL | 106 | Q96Q80 | |
| MKSIISLLFLLFLFI | 606 | Q00975 | |
| MRALVLLLSLFLLGG | 1 | P23280 | |
| VLAILLFLAAMLFVL | 3071 | Q9H251 | |
| MKFLLLVLAALGFLT | 1 | Q7Z7B7 | |
| MFSLKTLPFLLLLHV | 1 | P22894 | |
| GKSLFSLLEAMIFAL | 16 | Q8N3Y7 | |
| LNGILLFGHMLKIFL | 326 | P25092 | |
| MKILILGIFLFLCST | 1 | P00450 | |
| LLLFLFIIIFSLLGM | 661 | O60840 | |
| LKASMRELGLLIFFL | 321 | P16389 | |
| LMTLFFSGLILAILL | 231 | Q9BWQ8 | |
| LGRGLIVYLMFLLLK | 6 | O00533 | |
| MFKSLDLSLIVEFIL | 306 | Q9UQ53 | |
| LLAFVSAVLMGFSKL | 101 | P11166 | |
| MKALGAVLLALLLFG | 1 | Q8IV16 | |
| MKFLAVLVLLGVSIF | 1 | Q96DR8 | |
| MKLLVILLFSGLITG | 1 | Q9Y6X5 | |
| SLVLLGTGLFMKRFL | 221 | Q9H295 | |
| LKATLFMVLRNGLFV | 151 | Q8NGI3 | |
| MKIIILLGFLGATLS | 1 | A1E959 | |
| FIEKFLSLASEIMLL | 446 | Q6ZR08 | |
| EFSGLLLLKMLRSAI | 901 | Q6AI08 | |
| LKASMRELGLLIFFL | 391 | P22001 | |
| KLEAFFGFLITIMAL | 206 | P49281 | |
| MKFLLTTAFLILISL | 1 | P48167 | |
| MKVTGIFLLSALALL | 1 | P00995 | |
| MVKYLLLSILGLAFL | 11 | Q96PD4 | |
| MSLLGPKVLLFLAAF | 1 | Q13361 | |
| MKALIFAAAGLLLLL | 1 | O00254 | |
| GIFGTMLLIYLVKFL | 356 | A8MWK0 | |
| LLFLLAMGANATLLI | 36 | P0C7T3 | |
| MKLPLLLALLFGAVS | 1 | P13727 | |
| VLISYGFILLAILKM | 226 | Q8NG75 | |
| GFFLRLLTSKLMNDI | 801 | Q13315 | |
| KLLGILAFFNMQLLS | 1126 | Q13535 | |
| LLLFLFIIIFSLLGM | 656 | Q13936 | |
| IKDALGLLLFLLSLM | 226 | P00156 | |
| VFTSLFALEMLLKLL | 781 | O43497 | |
| MKSFSRILFLVFLLA | 1 | I3L273 | |
| FIRGMLKLILLLLFS | 341 | Q96SL1 | |
| IGKFMLALAFFAIII | 516 | P49326 | |
| MGLLGILCFLIFLGK | 1 | P01031 | |
| MKLRGVSLAAGLFLL | 1 | P29400 | |
| RLAMLDFVSSLGKLF | 666 | Q9NSG2 | |
| PFLKMSLLILLFLGL | 6 | A0A1B0GTR0 | |
| MHLTVFLLKGIVGFL | 1 | P22003 | |
| LLFAFGTLMGLRTLK | 16 | Q5VSG8 | |
| MKLSGMFLLLSLALF | 1 | Q6UWN8 | |
| SNKLLLALVMLFLFA | 151 | Q96MM7 | |
| LAFGSLIIALIQMFK | 516 | Q8NCS7 | |
| MALLLVSLLAFLSLG | 1 | P23945 | |
| IAEKVSLMGFLFLLG | 301 | A0AV02 | |
| ILLSLALYLLGMLAF | 106 | Q8N697 | |
| LGLLFGFAIMLVIAL | 806 | Q9ULF5 | |
| IAGILTFLALEKMFL | 156 | Q96H72 | |
| LIKLFYTLLIMGIFH | 1821 | Q92736 | |
| MLLLAAAFLVAFVLL | 1 | Q06136 | |
| RGLFLLKLGLSLLML | 336 | Q14CX5 | |
| SMKSIASLLLLLFLF | 646 | Q01668 | |
| LMILLGTLVFLFLNL | 131 | Q9NYV9 | |
| FLLLSLALADMFLGL | 71 | O14804 | |
| MKSSGLFPFLVLLAL | 1 | P03973 | |
| ALLGKFINVILALMA | 641 | O75069 | |
| MKLVFLVLLFLGALG | 1 | P02788 | |
| MKGSRALLLVALTLF | 1 | P0DMR2 | |
| LFGKAILRILIGMVF | 361 | Q9BX95 | |
| MKLLYFLLSALGLTV | 121 | Q14714 | |
| MKLTFFLGLLALISC | 1 | Q99935 | |
| LKMSLCLFILLFLTP | 6 | P23515 | |
| GLKMFLAALSLSFIA | 26 | Q9Y6L6 | |
| ILALTHLLFEFKGLM | 921 | Q5JTH9 | |
| ILLLKVAGFNLLMTL | 121 | P01848 | |
| MVFSLKVILFLSLLL | 1 | Q9Y6N3 | |
| MLALLLTAALIFFAI | 11 | O95406 | |
| SVVGFCLLVMLFLLK | 441 | Q16620 | |
| SLRLVFLLAFGLMII | 86 | Q86VR2 | |
| KLMASLFLSVFTLGL | 236 | Q9NUD9 | |
| FVLDMGFFETIKLLL | 101 | Q53HI1 | |
| VATSLLLLLFAIFMG | 306 | Q96AN5 | |
| LLLLFAIFMGLRASK | 311 | Q96AN5 | |
| ILLLKVAGFNLLMTL | 256 | P0DTU3 | |
| LFLSAFLLLGLFKAL | 416 | O15533 | |
| AVMFTLFGLNLLFKI | 156 | Q9H920 | |
| MKGSRALLLVALTLF | 1 | Q8TD33 | |
| MLSLLLLLLGLGSVF | 1 | A0A5B7 | |
| LLLLLFFMIIFAILG | 236 | Q9ULQ1 | |
| AMFLLVLGFIIALAL | 166 | O00526 | |
| ISLAIGLFFLMDVLL | 111 | Q6XPS3 | |
| EGLIFRFKFLMLITL | 426 | Q5T9L3 | |
| MSRKIEGFLLLLLFG | 1 | O15537 | |
| MAVGKFLLGSLLLLS | 1 | O60542 | |
| LLEMLLKVFALGLRG | 481 | Q8NHX9 | |
| FLIFLLMLILLGKGF | 251 | Q8NBT3 | |
| MTSKLAVALLAAFLI | 1 | P10145 | |
| FKELGLLLMYLAVGI | 321 | Q9H3M0 |